Abluminus NP - Concept Medical
Abluminus NP - Concept Medical - Stent Manufacturer in Surat, India

Polymer free Sirolimus

Eluting Stent System

Abluminus NP

Deals with the HARD facts with current DES

  • ABLUMINAL COATING - Abluminus NP

    ABLUMINAL COATING

    Drug is coated on the abluminal side only.
    Leading to mono directional drug release & less systemic exposure of drug which leads to faster healing

  • FUSION COATING - Abluminus NP

    FUSION COATING

    Drug is coated on stent as well as exposed parts of balloon & coated on the proximal and distal ends.
    Helps to address the entire disease area of lesion and address focal restenosis and edge restenosis.

  • POLYMER FREE NANO CARRIER DRUG DELIVERY - Abluminus NP

    POLYMER FREE NANO CARRIER DRUG DELIVERY

    Designed for acute as well as sustained drug transfer in arterial wall – leading to less chronic inflammation and improved vascular healing.

  • POLYMER FREE COATING - Abluminus NP

    POLYMER FREE COATING

    Proposed the shorter DAPT which helps to reduced bleeding risk in patients with high bleeding risk

Nanoactive Technology

Advantages of Nanoactive Technology

  • Reduces drug dose

  • Effective drug transfer to the deepest layer of the vessel

  • Protect drug by encapsulation- reduced in-transit drug loss

  • Better in-tissue bioavailability of drug

TECHNICAL SPECIFICATION

DRUG
Drug Sirolimus
Drug Dose 1.26 µg/mm²
Drug Carrier Phospholipid
Stent
Stent Material Cobalt Chromium Alloy L605
Strut Thickness 73 µm
Strut Width 80 µm (hinge) – 120 µm (strut)
Average Recoil Less than 5%
Average Foreshortening Less than 1% (Zero foreshortening design)
Delivery system
Delivery System RX stent delivery system
Nominal Pressure 8 bar
Rated Burst Pressure 14 bar
Guide Wire Compatibility (max.) 0.014’’
Guiding Catheter Compatibility 5F
Stent Diameter(mm) 2.25, 2.50, 2.75, 3.00, 3.50, 4.00
Stent Length(mm) 8, 12, 16, 20, 24, 28, 32, 36, 40

ORDERING INFORMATION

Stent Diameter 8 mm* 12 mm 16 mm 20 mm 24 mm 28 mm 32 mm 36 mm 40 mm
2.25mm EAP22508 EAP22512 EAP22516 EAP22520 EAP22524 EAP22528 EAP22532 EAP22536 EAP22540
2.50mm EAP25008 EAP25012 EAP25016 EAP25020 EAP25024 EAP25028 EAP25032 EAP25036 EAP25040
2.75mm EAP27508 EAP27512 EAP27516 EAP27520 EAP27524 EAP27528 EAP27532 EAP27536 EAP27540
3.00mm EAP30008 EAP30012 EAP30016 EAP30020 EAP30024 EAP30028 EAP30032 EAP30036 EAP30040
3.50mm EAP35008 EAP35012 EAP35016 EAP35020 EAP35024 EAP35028 EAP35032 EAP35036 EAP35040
4.00mm EAP40008 EAP40012 EAP40016 EAP40020 EAP40024 EAP40028 EAP40032 EAP40036 EAP40040

Clinical Programs

Sr. No Study Name Type of Study Target Patients Country Principal Investigator
Sr. No:  1 Study Name:   NANOACTIVE FIM Type of Study:  Prospective, Non-randomized, Multi Center Target Patients:  86 Patients Country:  India Principal Investigator:  Dr. Ashok Seth
Sr. No:  2 Study Name:   NANOACTIVE PMS Type of Study:  Prospective, Non-randomized, Multi Center Target Patients:  90 Patients Country:  India Principal Investigator:  Dr. Anil Potdar
“Confidence through evidence”
Get in Touch